SCHEMBL10184173

SCHEMBL10184173

Cc1nccn1CC(=O)N(c1ccn(C)n1)C1C(=O)N(C2CCCCC2)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 5/20 0.37
▸ OPRK1 P41145 5/20 0.37
▸ OPRL1 P41146 5/20 0.37
▸ IDH1 O75874 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.32
▸ F11 P03951 3/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NOS1 P29475 1/20 0.31
▸ CCKBR P32239 2/20 0.31
▸ CYP3A4 P08684 2/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ HTR3E A5X5Y0 1/20 0.30
▸ SLC22A2 O15244 1/20 0.30
▸ SLC22A1 O15245 1/20 0.30
▸ SLC22A3 O75751 1/20 0.30
▸ HTR3B O95264 1/20 0.30
▸ CHRNB2 P17787 1/20 0.30
▸ CHRNB4 P30926 1/20 0.30
▸ CHRNA3 P32297 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10185550 0.84 IDH1 (0.44) OPRM1OPRK1OPRL1IDH1KDM4E
SCHEMBL10183302 0.83 PTAFR (0.41) OPRM1OPRK1OPRL1IDH1
SCHEMBL10185959 0.83 IDH1 (0.52) OPRM1OPRK1OPRL1IDH1CCKBR
SCHEMBL10185987 0.83 IDH1 (0.42) OPRM1OPRK1OPRL1IDH1KDM4E
SCHEMBL10183799 0.83 IDH1 (0.42) OPRM1OPRK1OPRL1IDH1KDM4E
SCHEMBL10183929 0.82 CHRM2 (0.43) OPRM1OPRK1OPRL1KDM4EKMT2A
SCHEMBL10183670 0.80 TRPM8 (0.41) OPRM1OPRK1OPRL1TRPM8
SCHEMBL10185834 0.80 IDH1 (0.39) OPRM1OPRK1OPRL1IDH1KDM4E
SCHEMBL10185988 0.79 IDH1 (0.39) OPRM1OPRK1OPRL1IDH1CCKBR
SCHEMBL10183771 0.79 IDH1 (0.39) OPRM1OPRK1OPRL1IDH1CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback